Search research articles
Contact Us
Filters
Showing results (71-80 of 110) with videos related to
Page
of 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2017
A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal Cancer
Axel Grothey, Jonathan R Strosberg, Lindsay A Renfro, et al.
The Journal of the Association of Nurses in AIDS Care : JANAC
|
March 12, 2013
The impact of stressful life events, symptom status, and adherence concerns on quality of life in people living with HIV
Inge B Corless, Joachim Voss, A J Guarino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2017
Phase I/II Trial of Labetuzumab Govitecan (Anti-CEACAM5/SN-38 Antibody-Drug Conjugate) in Patients With Refractory or Relapsing Metastatic Colorectal Cancer
Efrat Dotan, Steven J Cohen, Alexander N Starodub, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2010
Phase II proof-of-concept study of pazopanib monotherapy in treatment-naive patients with stage I/II resectable non-small-cell lung cancer
Nasser Altorki, Maureen E Lane, Thomas Bauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 27, 2017
Therapy of Advanced Non-Small-Cell Lung Cancer With an SN-38-Anti-Trop-2 Drug Conjugate, Sacituzumab Govitecan
Rebecca Suk Heist, Michael J Guarino, Gregory Masters, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 26, 2021
Veliparib in combination with carboplatin/paclitaxel-based chemoradiotherapy in patients with stage III non-small cell lung cancer
David E Kozono, Thomas E Stinchcombe, Joseph K Salama, et al.
Cancer
|
May 10, 2012
Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial
Allyson J Ocean, Kenneth L Pennington, Michael J Guarino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 7, 2017
Therapy of Small Cell Lung Cancer (SCLC) with a Topoisomerase-I-inhibiting Antibody-Drug Conjugate (ADC) Targeting Trop-2, Sacituzumab Govitecan
Jhanelle E Gray, Rebecca S Heist, Alexander N Starodub, et al.
AIDS Care
|
July 11, 2012
Mediators of antiretroviral adherence: a multisite international study
I B Corless, A J Guarino, P K Nicholas, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 19, 2015
(90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies
Vincent J Picozzi, Ramesh K Ramanathan, Maeve A Lowery, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 110) with videos related to
Sort By:
Page
of 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2017
A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal Cancer
Axel Grothey, Jonathan R Strosberg, Lindsay A Renfro, et al.
The Journal of the Association of Nurses in AIDS Care : JANAC
|
March 12, 2013
The impact of stressful life events, symptom status, and adherence concerns on quality of life in people living with HIV
Inge B Corless, Joachim Voss, A J Guarino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2017
Phase I/II Trial of Labetuzumab Govitecan (Anti-CEACAM5/SN-38 Antibody-Drug Conjugate) in Patients With Refractory or Relapsing Metastatic Colorectal Cancer
Efrat Dotan, Steven J Cohen, Alexander N Starodub, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2010
Phase II proof-of-concept study of pazopanib monotherapy in treatment-naive patients with stage I/II resectable non-small-cell lung cancer
Nasser Altorki, Maureen E Lane, Thomas Bauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 27, 2017
Therapy of Advanced Non-Small-Cell Lung Cancer With an SN-38-Anti-Trop-2 Drug Conjugate, Sacituzumab Govitecan
Rebecca Suk Heist, Michael J Guarino, Gregory Masters, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 26, 2021
Veliparib in combination with carboplatin/paclitaxel-based chemoradiotherapy in patients with stage III non-small cell lung cancer
David E Kozono, Thomas E Stinchcombe, Joseph K Salama, et al.
Cancer
|
May 10, 2012
Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial
Allyson J Ocean, Kenneth L Pennington, Michael J Guarino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 7, 2017
Therapy of Small Cell Lung Cancer (SCLC) with a Topoisomerase-I-inhibiting Antibody-Drug Conjugate (ADC) Targeting Trop-2, Sacituzumab Govitecan
Jhanelle E Gray, Rebecca S Heist, Alexander N Starodub, et al.
AIDS Care
|
July 11, 2012
Mediators of antiretroviral adherence: a multisite international study
I B Corless, A J Guarino, P K Nicholas, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 19, 2015
(90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies
Vincent J Picozzi, Ramesh K Ramanathan, Maeve A Lowery, et al.
Page
of 11